Shine blames delays in class action settlement approval for 90% profit drop
Business of Law 2023-08-29 11:03 pm By Christine Caulfield
Please login to bookmark Close

Delays in court approval of settlements in their pelvic mesh class actions against US giants Johnson & Johnson and Boston Scientific have been blamed for Shine Lawyers’ 89.39 per cent decline in net profits for 2023.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au